Effect of Mammalian Target of Rapamycin Inhibition on Activated Regulatory T-Cell Expansion in Kidney Transplantation
Transplantation Proceedings · 2023
DOI: 10.1016/j.transproceed.2023.03.037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Yusuke Tomita und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplant Surgery, Tokai University School of Medicine, Kanagawa, Japan. Electronic address: ytomita@tokai.ac.jp. Hauptthemen laut MEDLINE: Sirolimus, Kidney Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
BACKGROUND: The mammalian target of rapamycin (mTOR) plays a critical role in the host immune response in organ transplantation. This study evaluates the regulatory benefits of mTOR inhibitors in kidney transplant recipients (KTRs). METHODS: The mTOR-dependent immune-regulating effects in KTRs were evaluated by examining T-cell subsets among peripheral blood mononuclear cells from 79 KTRs. Recipients included an early introduction of everolimus (EVR) and reduced-exposure tacrolimus group (n = 46) and a standard tacrolimus-based without EVR (non-EVR) group (n = 33). RESULTS: Trough concentrations of tacrolimus at 3 months and 1 year were significantly lower in the EVR group than the non-EVR group (both P < .001). In addition, the respective proportions of patients without estimated glomerular filtration rate < 20% in the EVR and non-EVR groups were 100% and 93.3% at 1 year, 96.3% and 89.7% at 2 years, and 96.3% and 89.7% at 3 years after blood collection, respectively (P = .079). The frequencies of CD3+ T cells and CD4+ T cells among peripheral blood mononuclear cells were comparable between groups. Total CD25highCD127-CD4+ regulatory T (Treg) cells were similar in the EVR and non-EVR groups. In contrast, circulating CD45RA-CD25highCD127-CD4+ activated Treg cells were significantly higher in the EVR group (P= .008). CONCLUSION: These results suggest that the early introduction of mTOR benefits long-term kidney graft function and circulating activated Treg-cell expansion in KTRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Transplant Surgery, Tokai University School of Medicine, Kanagawa, Japan. Electronic address: ytomita@tokai.ac.jp.
- Department of Transplant Surgery, Tokai University School of Medicine, Kanagawa, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Tomita, Y., Uehara, S., Takiguchi, S., & Nakamura, M. (2023). Effect of Mammalian Target of Rapamycin Inhibition on Activated Regulatory T-Cell Expansion in Kidney Transplantation. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.03.037
Vancouver
Tomita Y, Uehara S, Takiguchi S, Nakamura M. Effect of Mammalian Target of Rapamycin Inhibition on Activated Regulatory T-Cell Expansion in Kidney Transplantation. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.03.037
BibTeX
@article{Tomita2023,
author = {Tomita, Yusuke and Uehara, Saeko and Takiguchi, Shinya and Nakamura, Michio},
title = {Effect of Mammalian Target of Rapamycin Inhibition on Activated Regulatory T-Cell Expansion in Kidney Transplantation},
journal = {Transplantation Proceedings},
year = {2023},
doi = {10.1016/j.transproceed.2023.03.037}
}
EUVIMED